$ORKA
Oruka Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ORKA up today? It is at $92.29 (+0.20%), and our scanner flagged it 75 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ORKA spikes, and full due diligence on ORKA — key stats, earnings, dilution and insider activity. Free.
Get free $ORKA alerts the moment volume spikes
Our scanner flagged $ORKA 75 times in the last 30 days. Create a free account to track $ORKA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $92.29
- Change today
- +0.20%
- Previous close
- $92.11
- 52-week range
- $14.66 – $115.52
- Market cap
- $6.13B
- Institutional own.
- 99.9%
- Total held
- 99.9%
- Tradeable float
- 64K 0% of shares · after <1% insiders + 100% institutions
- Short interest
- 8.3M ▲ +3% vs prior · as of 2026-08-14
- Days to cover
- 11.3d
- Avg daily volume
- 914K
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5mthin
- 516x
- 15mthin
- 689x
- 1hthin
- 689x
- 1D
- 0.0x
Get free ORKA + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $ORKA moving today?
Here is the latest on ORKA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ORKA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystExecutive / Board Change, from an SEC filing. Read it →Latest filing4Statement of changes in beneficial ownership of securitiesSep 1, 2026 · todayAnalyst data via Nasdaq. Not investment advice.
Insiders
2 buys, 17 sells last 3 months (9/33 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Edwards Larry Todd Officer | Acquired (grant/award) | +100K 0.2% of company | n/a | 100K | n/a | Aug 24, 26 |
Goncalves Joana Officer | Sold (automatic/other) | -7K 0.01% of company | sold 18% | 33K | $768K at $109.65 | Aug 17, 26 |
Goncalves Joana Officer | Other | 7K 0.01% of company | added 21% | 40K | $48K at $6.84 | Aug 17, 26 |
Quinlan Paul T Officer | Sold (automatic/other) | -52K 0.08% of company | sold 63% | 31K | $5.5M at $106.05 | Aug 14, 26 |
Quinlan Paul T Officer | Other | 52K 0.08% of company | added 100% | 83K | $406K at $7.80 | Aug 14, 26 |
Agarwal Arjun Officer | Sold (automatic/other) | -10K 0.02% of company | sold 40% | 15K | $1.0M at $104.67 | Aug 13, 26 |
Agarwal Arjun Officer | Other | 10K 0.02% of company | added 65% | 25K | $125K at $12.50 | Aug 13, 26 |
Goncalves Joana Officer | Sold (automatic/other) | -7K 0.01% of company | sold 18% | 33K | $591K at $84.36 | Jul 15, 26 |
Goncalves Joana Officer | Other | 7K 0.01% of company | added 21% | 40K | $48K at $6.84 | Jul 15, 26 |
Agarwal Arjun Officer | Sold (automatic/other) | -10K 0.02% of company | sold 40% | 15K | $831K at $83.07 | Jul 13, 26 |
Agarwal Arjun Officer | Other | 10K 0.02% of company | added 65% | 25K | $125K at $12.50 | Jul 13, 26 |
Sandler Laura Lee Officer | Sold (automatic/other) | -5K | sold 2.1% | 236K | $469K at $93.85 | Jul 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $ORKA runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 4,768,262 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $500.0M in size · Priced at $104.86/share
- At-the-market (ATM) program — sells new shares into the market gradually over time · About $1.0B in size
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$ORKA Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$ORKA Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to ORKA
Comparable names in pharmaceutical preparations, closest in size first.
ORKA stock FAQ
Why is $ORKA moving today?
Here is the latest on ORKA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ORKA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the ORKA stock price today?
ORKA last traded at $92.29, up 0.20% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live ORKA alerts?
The ORKA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ORKA 75 times in the last 30 days.
What exchange is ORKA on?
ORKA (Oruka Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $6.13B in the PHARMACEUTICAL PREPARATIONS sector.
Is ORKA good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ORKA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.